Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ellin Berman

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|February 22, 2011
NCCN Task Force report: tyrosine kinase inhibitor therapy selection in the management of patients with chronic myelogenous leukemiaSusan O'Brien, Ellin Berman, Joseph O Moore, et al.
Blood|October 7, 2011
Phase 1/2 study to assess the safety, efficacy, and pharmacokinetics of barasertib (AZD1152) in patients with advanced acute myeloid leukemiaBob Löwenberg, Petra Muus, Gert Ossenkoppele, et al.
Blood|April 20, 2010
Vaccination with synthetic analog peptides derived from WT1 oncoprotein induces T-cell responses in patients with complete remission from acute myeloid leukemiaPeter G Maslak, Tao Dao, Lee M Krug, et al.
Nature|January 17, 2014
Leukaemogenesis induced by an activating β-catenin mutation in osteoblastsAruna Kode, John S Manavalan, Ioanna Mosialou, et al.
Haematologica|August 18, 2025
Two decades of single-institution data reveal rare long-term survivors of relapsed/refractory Burkitt lymphomaRabeya Molla, Kurt Bantilan, Ellin Berman, et al.
Haematologica|October 21, 2017
Hsp90 inhibition disrupts JAK-STAT signaling and leads to reductions in splenomegaly in patients with myeloproliferative neoplasmsGabriela S Hobbs, Amritha Varshini Hanasoge Somasundara, Maria Kleppe, et al.
Journal of Hematology & Oncology|January 7, 2022
Retrospective analysis of arterial occlusive events in the PACE trial by an independent adjudication committeeJames L Januzzi, Joseph M Garasic, Scott E Kasner, et al.
Journal of Hematology & Oncology|March 23, 2022
Correction: Retrospective analysis of arterial occlusive events in the PACE trial by an independent adjudication committeeJames L Januzzi, Joseph M Garasic, Scott E Kasner, et al.
Blood|August 21, 2014
Inhibition of leukemia cell engraftment and disease progression in mice by osteoblastsMaria Krevvata, Barbara C Silva, John S Manavalan, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 19, 2007
Chronic myelogenous leukemiaSusan O'Brien, Ellin Berman, Kapil Bhalla, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Journal of the National Comprehensive Cancer Network : JNCCN|February 22, 2011
NCCN Task Force report: tyrosine kinase inhibitor therapy selection in the management of patients with chronic myelogenous leukemiaSusan O'Brien, Ellin Berman, Joseph O Moore, et al.
Blood|October 7, 2011
Phase 1/2 study to assess the safety, efficacy, and pharmacokinetics of barasertib (AZD1152) in patients with advanced acute myeloid leukemiaBob Löwenberg, Petra Muus, Gert Ossenkoppele, et al.
Blood|April 20, 2010
Vaccination with synthetic analog peptides derived from WT1 oncoprotein induces T-cell responses in patients with complete remission from acute myeloid leukemiaPeter G Maslak, Tao Dao, Lee M Krug, et al.
Nature|January 17, 2014
Leukaemogenesis induced by an activating β-catenin mutation in osteoblastsAruna Kode, John S Manavalan, Ioanna Mosialou, et al.
Haematologica|August 18, 2025
Two decades of single-institution data reveal rare long-term survivors of relapsed/refractory Burkitt lymphomaRabeya Molla, Kurt Bantilan, Ellin Berman, et al.
Haematologica|October 21, 2017
Hsp90 inhibition disrupts JAK-STAT signaling and leads to reductions in splenomegaly in patients with myeloproliferative neoplasmsGabriela S Hobbs, Amritha Varshini Hanasoge Somasundara, Maria Kleppe, et al.
Journal of Hematology & Oncology|January 7, 2022
Retrospective analysis of arterial occlusive events in the PACE trial by an independent adjudication committeeJames L Januzzi, Joseph M Garasic, Scott E Kasner, et al.
Journal of Hematology & Oncology|March 23, 2022
Correction: Retrospective analysis of arterial occlusive events in the PACE trial by an independent adjudication committeeJames L Januzzi, Joseph M Garasic, Scott E Kasner, et al.
Blood|August 21, 2014
Inhibition of leukemia cell engraftment and disease progression in mice by osteoblastsMaria Krevvata, Barbara C Silva, John S Manavalan, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 19, 2007
Chronic myelogenous leukemiaSusan O'Brien, Ellin Berman, Kapil Bhalla, et al.
Pageof 5